Potential coronavirus drugs, illustration
Bildnummer 13196089
| Illustration of molecules of the protease inhibitor camostat mesilate (right), molecules of the nucleotide analogue remdesivir (left) and a SARS-CoV-2 coronavirus particle (centre). Camostat and remdesivir are being investigated as treatments for covid-19, the respiratory infection caused by the Sars-CoV-2 (previously 2019-nCoV) virus. Camostat blocks the virus from entering human cells. Remdesivir disrupts the production of RNA (ribonucleic acid), the coronavirus genome and so stops the virus from replicating. Sars-CoV-2 was first identified in Wuhan, China, in December 2019. As of March 2020, the virus has spread to many countries worldwide and has been declared a pandemic. Over 100, 000 have been infected with several thousand deaths. | |
| Lizenzart: | Lizenzfrei |
| Credit: | Science Photo Library / Gaertner, Juan |
| Modell-Rechte: | nicht erforderlich |
| Eigentums-Rechte: | nicht erforderlich |
| Restrictions: | - |
Preise für dieses Bild ab 29 €
Für digitale Nutzung (72 dpi)
ab 29 €
Für Druckauflösung (300 dpi)
ab 300 €
Keywords
- 2019,
- 2019-nCoV,
- ansteckend,
- antiviral,
- Arzneimittel,
- Atemwege,
- Ausbruch,
- Behandlung,
- Biochemie,
- biochemisch,
- Biologie,
- biologisch,
- chemische Formel,
- China,
- Coronavirus,
- Covid-19,
- Epidemie,
- Erreger,
- experimentell,
- hcov,
- Illustration,
- Kunstwerk,
- Lungenentzündung,
- Medizin,
- medizinisch,
- Mikrobe,
- Mikrobiologie,
- mikrobiologisch,
- Mikroorganismus,
- Molekül,
- molekulare Struktur,
- Molekülmodell,
- Neu,
- Niemand,
- Pandemie,
- Partikel,
- Pharmakologie,
- pharmakologisch,
- pharmazeutisch,
- RNA-Virus,
- SARS-CoV-2,
- tödlich,
- viral,
- Virion,
- Virologie,
- Virus